X
+ Watchlist
AXA Framlington Biotech Fund
FRABIRA:LN
117.00
USd
0.80
0.68%
As of 4/23/2018
Fund Type
Unit Trust
52Wk Range
99.64 - 129.00
1 Yr Return
15.16%
YTD Return
3.36%
Previous Close
117.80
52Wk Range
99.64 - 129.00
1 Yr Return
14.82%
YTD Return
3.36%
Fund Type
Unit Trust
Objective
Health Care Sector
Asset Class Focus
Equity
Geographic Focus
Global
NAV (on 04/23/2018)
117
Total Assets (m GBP) (on 04/23/2018)
466.381
Inception Date
01/23/2015
Last Dividend (on 03/01/2018)
-
Dividend Indicated Gross Yield
-
Fund Managers
LINDEN THOMSON
Front Load Fee
0.00%
Back Load Fee
-
Redemption Fee
-
12b-1 Fee
-
Current Mgmt Fee
1.75%
Expense Ratio
-
Profile
AXA Framlington Biotech Fund is an authorized unit trust incorporated in the United Kingdom. The aim of the Fund is to provide long-term capital appreciation The Fund will invest principally in equity securities of companies in the biotechnology, genomic and medical research industries worldwide.
Address
AXA Framlington Unit Management Ltd7 Newgate Street
London EC1A 7NX
United Kingdom
Phone
44-207-374-4100 Website
www.axa-framlington.com